[go: up one dir, main page]

FI921456A7 - Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, förfaranden för deras framställning och deras användning i läkemedel - Google Patents

Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, förfaranden för deras framställning och deras användning i läkemedel Download PDF

Info

Publication number
FI921456A7
FI921456A7 FI921456A FI921456A FI921456A7 FI 921456 A7 FI921456 A7 FI 921456A7 FI 921456 A FI921456 A FI 921456A FI 921456 A FI921456 A FI 921456A FI 921456 A7 FI921456 A7 FI 921456A7
Authority
FI
Finland
Prior art keywords
trifluoromethyluridines
dideoxy
pharmaceuticals
substituted
preparation
Prior art date
Application number
FI921456A
Other languages
English (en)
Finnish (fi)
Other versions
FI921456L (fi
FI921456A0 (fi
Inventor
Rainer Neumann
Dieter Häbich
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI921456A0 publication Critical patent/FI921456A0/fi
Publication of FI921456A7 publication Critical patent/FI921456A7/sv
Publication of FI921456L publication Critical patent/FI921456L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI921456A 1991-04-05 1992-04-02 Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel FI921456L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4110977A DE4110977A1 (de) 1991-04-05 1991-04-05 Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (3)

Publication Number Publication Date
FI921456A0 FI921456A0 (fi) 1992-04-02
FI921456A7 true FI921456A7 (sv) 1992-10-06
FI921456L FI921456L (fi) 1992-10-06

Family

ID=6428857

Family Applications (1)

Application Number Title Priority Date Filing Date
FI921456A FI921456L (fi) 1991-04-05 1992-04-02 Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, foerfaranden foer deras framstaellning och deras anvaendning i laekemedel

Country Status (15)

Country Link
EP (1) EP0507188A1 (sv)
JP (1) JPH05148261A (sv)
KR (1) KR920019813A (sv)
CN (1) CN1065462A (sv)
AU (1) AU640860B2 (sv)
CA (1) CA2064916A1 (sv)
CS (1) CS92092A3 (sv)
DE (1) DE4110977A1 (sv)
FI (1) FI921456L (sv)
HU (1) HUT60748A (sv)
IE (1) IE921083A1 (sv)
IL (1) IL101482A0 (sv)
NO (1) NO921086L (sv)
NZ (1) NZ242205A (sv)
TW (1) TW205043B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1050846C (zh) * 1995-08-03 2000-03-29 中国医学科学院医药生物技术研究所 一种抗肿瘤抗生素云南霉素及其制备方法
CA2446620C (en) 2001-05-18 2013-11-19 Rakesh Kumar Antiviral nucleosides
CN100334100C (zh) * 2004-01-17 2007-08-29 杭州富邦生物制药有限公司 5－三氟甲基－2’－脱氧尿苷的合成方法
JP4603274B2 (ja) * 2004-02-24 2010-12-22 三井化学株式会社 ２’−デオキシ−５−トリフルオロメチルウリジンの製造方法
JP5485138B2 (ja) * 2008-03-28 2014-05-07 浜理薬品工業株式会社 エチニルチミジン化合物の精製方法
EP2277878B1 (en) 2008-04-10 2014-09-17 Hamari Chemicals, Ltd. Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048877A1 (de) * 1980-12-23 1982-07-08 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Pyrimidinnucleosid-phosphonate, verfahren zur herstellung und sie enthaltende mittel
PT82580B (pt) * 1985-05-15 1989-01-17 Wellcome Found Processo para a preparacao de 2',3'- didesoxinucleosidos e de composicoes farmaceuticas que os contem
DE3650741T2 (de) * 1985-09-17 2000-10-12 The Wellcome Foundation Ltd., Greenford Kombination therapeutische Nukleoside mit weiteren therapeutisch wirksamen Komponenten.
CA1327000C (en) * 1987-08-07 1994-02-15 David L.J. Tyrrell Antiviral therapy for hepatitis b
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
SE8802173D0 (sv) * 1988-06-10 1988-06-10 Astra Ab Pyrimidine derivatives
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
WO1990014079A1 (en) * 1989-05-15 1990-11-29 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method of treatment of hepatitis
NZ234534A (en) * 1989-07-17 1994-12-22 Univ Birmingham Pyrimidine 4'-thionucleoside derivatives and their preparation; intermediates therefor

Also Published As

Publication number Publication date
EP0507188A1 (de) 1992-10-07
TW205043B (sv) 1993-05-01
NO921086D0 (no) 1992-03-19
HU9201117D0 (en) 1992-06-29
FI921456L (fi) 1992-10-06
KR920019813A (ko) 1992-11-20
CN1065462A (zh) 1992-10-21
NO921086L (no) 1992-10-06
NZ242205A (en) 1993-04-28
CS92092A3 (en) 1992-12-16
IL101482A0 (en) 1992-12-30
HUT60748A (en) 1992-10-28
JPH05148261A (ja) 1993-06-15
FI921456A0 (fi) 1992-04-02
AU1219092A (en) 1992-10-08
IE921083A1 (en) 1992-10-07
DE4110977A1 (de) 1992-10-08
AU640860B2 (en) 1993-09-02
CA2064916A1 (en) 1992-10-06

Similar Documents

Publication Publication Date Title
FI952179A7 (sv) Nya 3,3-difenylpropylaminer, användning och framställning därav
FI941538L (sv) Partiklar, ett förfarande för framställning av dem och deras användning
FI962589L (sv) 2,4-disulfofenylbutylnitron dess salter, och deras användning som farmaceutiska ämnen
FI934220A7 (sv) Piperidinderivat, framställning därav och användning därav vid en terapi
FI955248A7 (sv) 1-Bifenylmetylimidazolderivat, framställning och terapeutisk användning av dessa
FI990387A7 (sv) Tienopyrimidinderivat, deras framställning och användning
FI955140A7 (sv) Nya kinoxalindionderivat, deras framställning och användning i läkemed el
FI944600A7 (sv) Imidazol-4-ylpiperidinderivat, framställning av dessa och användning av dessa inom terapin
FI944821L (sv) Galantaminderivat, förfarande för framställning av dessa och användning av dessa i läkemedel
FI944822L (sv) Galantaminderivat, förfarande för framställning av dessa och användning av dessa i läkemedel
FI944823L (sv) Galantaminderivat, förfarande för framställning av dessa och användning av dessa i läkemedel
FI911615A7 (sv) Nya 4-kinolyl-dihydropyridiner, förfaranden för deras framställning och deras användning i läkemedel
FI932145A7 (sv) Nya b-karbolinderivat, deras framställning och användning i läkemedel
FI922982A7 (sv) 2-aminopyrimidin-4-karboxamidderivat, framställning av dessa och terapeutisk användning av dessa
FI934680A7 (sv) Arylmorfolin, framställning och använding
FI930716A7 (sv) Nya arylkarbonylaminoalkyldihydrooxopyridiner, framställning och användning av dessa
FI953956A7 (sv) 2,3-ringkondenserade 1,4-dihydropyridiner, förfaranden för framställning av dessa och användning av dessa som läkemedel
FI900627A7 (sv) 2,3,23-trihydroxiurs-12-en och dess derivat, förfarande för deras framställning och deras användning
FI930293A7 (sv) Nya heteroaryloxi-b-karboliner, deras framställning och användning i l äkemedel
FI923458A7 (sv) 4,5-cykloalkano-3-benzazepin-7-olderivat och deras användning
FI885056A7 (sv) Nya fluormetoxifenyldihydropyridiner, förfaranden för deras framställning och deras användning i läkemedel
FI902901A7 (sv) Dibenzol/1,5/dioxocin-5-one-derivat, deras användning i läkemedel och förfarande för deras framställning
FI920663A7 (sv) Polyhydroxicyklopentanderivat, deras framställning och terapeutiska användning
FI921814A7 (sv) 2-aminopyrimidin-4-karboxiamidderivat, deras framställning och terapeutisk användning av dem
FI921456A7 (sv) Substituerade 2',3'-didesoxi-5-trifluormetyluridiner, förfaranden för deras framställning och deras användning i läkemedel

Legal Events

Date Code Title Description
FD Application lapsed